Biosystemix

Biosystemix provides cutting-edge service solutions in advanced data analysis and predictive modeling, for personalized medicine, drug discovery and development, and disease genomics. Our technologies cover the full range of computational methods and domain expertise required for an innovative biomedical data analysis offering: Statistical data ass... essment, exploratory analysis and visualization Advanced data mining and predictive modeling Data-driven, gene network reverse engineering and pathway discovery To help our customers meet their objectives, our service solutions are currently being applied to: Identifying powerful marker sets and integrating them into predictive models of Transplant rejection, i.e., expression-based prediction of acute and chronic graft vs. host disease (collaboration with Genome Canada and Genome Québec supported partners at leading Montreal and Torontouniversity centers) Disease prognosis in follicular lymphoma (cancer collaboration with Queen's University, Kingston, Ontario, Canada) IFNb (Interferon beta) response in MS (multiple sclerosis) based on gene expression data (collaboration with UCSF [University of California San Francisco]) Discovering mechanisms and signaling pathways for Understanding gene network interactions in toxicity (collaboration with University of Michigan) T-cell maturation models (collaboration with Genome Canada and Genome Québec partners) Immune signaling networks in MS patients (collaboration with UCSF) The higher definition achieved with Biosystemix expertise supports predictors and models that show superior performance, and often enables solutions where conventional approaches may come up empty-handed. Given today's biomedical investments into data-intensive molecular and clinical R&D for diagnostic/prognostic marker discovery, pathway inference and compound efficacy/toxicity evaluation, Biosystemix advanced analysis is helping our partners obtain more value from these efforts.Read More